Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

[Answers to questions on rheumatoid arthritis from Practice No. 23].

Mertens JC, Kaplan V, Ciurea A.

Praxis (Bern 1994). 2008 Dec 3;97(24):1309. doi: 10.1024/1661-8157.97.24.1309. German. No abstract available.

PMID:
19048512
2.

[Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations].

Nasonov EL.

Ter Arkh. 2007;79(5):5-8. Russian. No abstract available.

PMID:
17672066
3.

Treatment, management, and monitoring of established rheumatoid arthritis.

Bingham CO 3rd, Miner MM.

J Fam Pract. 2007 Oct;56(10 Suppl Rapid):S1-7; quiz S8. Review. No abstract available.

PMID:
17949607
4.

Questions and answers in 2008 about biologics in rheumatoid arthritis.

Weinblatt ME.

J Rheumatol. 2008 Sep;35(9):1878-81. No abstract available.

PMID:
18785296
5.

[New ways in the management of rheumatoid arthritis in Hungary].

Gergely P, Poór G.

Lege Artis Med. 2007 Oct;17(10):657-64. Review. Hungarian.

PMID:
19227595
6.

Tumor necrosis factor inhibitors for rheumatoid arthritis.

Scott DL, Kingsley GH.

N Engl J Med. 2006 Aug 17;355(7):704-12. Review. No abstract available.

PMID:
16914706
7.

The 'alphabet' of rheumatoid arthritis treatment.

Capriotti T.

Medsurg Nurs. 2004 Dec;13(6):420-8. Review. No abstract available.

PMID:
15714747
8.

Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors.

Anderson P, Louie J, Lau A, Broder M.

Curr Rheumatol Rep. 2005 Mar;7(1):3-9. Review. No abstract available.

PMID:
15760575
9.

Trials reveal promising options for treating juvenile rheumatoid arthritis.

Hampton T.

JAMA. 2008 Jan 2;299(1):27-8. doi: 10.1001/jama.2007.36. No abstract available.

PMID:
18167400
10.

Biological disease modifying anti-rheumatic drugs.

Cranwell-Bruce LA.

Medsurg Nurs. 2011 May-Jun;20(3):147-50. No abstract available.

PMID:
21786492
11.

New drugs for rheumatoid arthritis.

Olsen NJ, Stein CM.

N Engl J Med. 2004 May 20;350(21):2167-79. Review. No abstract available.

PMID:
15152062
12.

[Danish data document therapeutic effect differences of tumor necrosis factor inhibitors in patient with rheumatoid arthritis].

Hetland ML.

Ugeskr Laeger. 2010 Jun 28;172(26):2003; author reply 2003-4. Danish. No abstract available.

PMID:
20681045
13.

Anti-TNF-alpha therapies: they are all the same (aren't they?).

Mpofu S, Fatima F, Moots RJ.

Rheumatology (Oxford). 2005 Mar;44(3):271-3. Review. No abstract available.

PMID:
15561736
14.

Rheumatoid arthritis.

Burchini G, Orsi C.

N Engl J Med. 2004 Sep 23;351(13):1360-1; author reply 1360-1. No abstract available.

PMID:
15385669
15.

Differential drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.

Sidiropoulos PI, Boumpas DT.

Ann Rheum Dis. 2006 Jun;65(6):701-3. No abstract available.

PMID:
16699049
16.

TNF inhibitors: a new age in rheumatoid arthritis treatment.

Anderson DL.

Am J Nurs. 2004 Feb;104(2):60-8; quiz 68-9. Review. No abstract available.

PMID:
14767382
17.

[Anti-TNF therapy in rheumatoid arthritis].

Yakeuchi T, Amano K.

Nihon Rinsho Meneki Gakkai Kaishi. 2004 Feb;27(1):7-15. Review. Japanese. No abstract available.

PMID:
15045810
18.

Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.

Abadoglu O, Epozturk K, Atayik E, Kaptanoglu E.

J Investig Allergol Clin Immunol. 2011;21(4):319-21. No abstract available.

PMID:
21721382
19.

[TNF targetting therapy for rheumatoid arthritis].

Takeuchi T.

Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1787-94. Review. Japanese. No abstract available.

PMID:
17037316
20.

Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register).

Iannone F, Ferraccioli G, Gremese E, Lapadula G; Gruppo Italiano di Studio sulle Early Arthritides (GISEA)..

Ann Rheum Dis. 2014 Jun;73(6):e31. doi: 10.1136/annrheumdis-2013-205011. No abstract available.

PMID:
24368512
Items per page

Supplemental Content

Support Center